RxDoctor Payments Data

Sydney Johnston, PA

Physician Assistant · Lincoln, NENPI 1619502341

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Sanofi at 36.2% of the total. 2025 is the largest year on record at $1,330, 5.7 times the $234 reported in 2021. Among physician assistant clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,499in general payments, 2019–2025

Across 170 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$1K
  • AbbVie$501
  • AstraZeneca$475
  • Lilly USA, LLC$227
  • Pfizer$111
  • Sanofi-aventis U.S. LLC$72
  • plus $846 from 24 others

What the payments were for

  • Food & beverage$3,42798%
  • Education$722%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,499 in reported general payments places this provider in the 90th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska →

Medicare billing

Part B allowed, 2024
$89,682
Medicare patients
157
Services billed
2,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$20,307
XareltoRivaroxaban16$8,537
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,643
Albuterol Sulfate HfaAlbuterol Sulfate32$885
Fluticasone Propionate23$413
Montelukast Sodium48$401
Azelastine Hcl13$385
Lisinopril29$260
Levocetirizine Dihydrochloride18$233
Metoprolol Succinate11$208
Levothyroxine Sodium24$201
Losartan Potassium15$201
Atorvastatin Calcium33$190
Omeprazole14$190
Amlodipine Besylate12$155

Paid to pharmacies, not to this prescriber.

Other physician assistant in Lincoln

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →